ArticleClinical and experimental nephrology2020

Should rituximab be administered before cyclophosphamide as a first-line steroid-sparing agent to young children with steroid-dependent nephrotic syndrome?

Shuichiro Fujinaga et al.PubMed ↗Publisher ↗

No numbers read from the abstract.